Related article in
-
ArticleMarch 31, 2000
0
803
357
The Significance of ALIP in Acute Myeloid Leukemia after Chemotherapy : A Retrospective Study of Clinical and Histopathologic Aspects
In Ho Kim, Dong Wan Kim, Won Sup Lee, Min Hee Yoo, Seon Yang Park, Byoung Kook Kim, Noe Kyeong Kim, Su Shin, Young Kyung Lee, Han Ik Cho
Korean J Hematol 2000; 35(1): 40-49 -
ArticleJune 30, 2000
0
630
105
The Frequency and Clinical Significance of Multidrug Resistance-1 (MDR-1) Gene Expression in Acute Myeloid Leukemia
Jin Ho Baek, Sung Won Park, Dong Hwan Kim, Jin Tae Jung, Dong Seok Kwak, So Hyang Park, Sang Kyun Sohn, Jang Soo Suh, Kun Soo Lee, Jae Tae Lee, Kyu Bo Lee
Korean J Hematol 2000; 35(2): 117-125 -
ArticleMarch 31, 2001
0
683
222
Clinical Implication of Serum Anti-p53 Antibodies and Overexpression of p53 Protein in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Joeng Seon Park,Tae Hee Park, Tae Seong Park, Ju Seop Jeong, Young Tak Lim, Eun Yup Lee, Goon Jae Cho
Korean J Hematol 2001; 36(1): 1-8 -
ArticleSeptember 30, 2001
0
711
798
Clinical Outcome of the Chromosomal Abnormalities in Acute Myeloid Leukemia with M2 Subtype
Hyuk Chan Kwon, Seung Hyun Sohn, Seong Hyun Kim, Seong Geun Kim, Bong Gun Suh, Jae Seok Kim, Hyo Jin Kim, Jin Yeong Han
Korean J Hematol 2001; 36(3): 181-188 -
ArticleSeptember 30, 2001
0
718
802
Clinical Significance of CD34 Expression in Patients with Acute Myeloid Leukemia
Je Jung Lee, Ik Joo Chung, Duk Hwan Yang, Sang Hee Cho, Hyeoung Joon Kim, Duck Cho, Dong Wook Ryang, Chan Eun Nam
Korean J Hematol 2001; 36(3): 197-203 -
ArticleDecember 31, 2001
0
735
222
Treatment of Refractory and Relapsed Acute Myeloid Leukemia with High-dose Cytarabine and Idarubicin
Hyo Rak Lee, Se Hoon Park, Seo Young Song, Joon Oh Park, Soon Il Lee, Ki Hyun Kim, Won Seog Kim, Chul Won Jung, Young Hyuck Im, Won Ki Kang, Keun Chil Park, Hong Ghi Lee, Gu Ehn Park, Sun Hee Kim
Korean J Hematol 2001; 36(4): 299-305 -
ArticleJune 30, 2002
0
624
694
Clinical Significance of the Chromosomal Abnormalities and Immunophenotype in Acute Myeloid Leukemia
Hyuk Chan Kwon
Korean J Hematol 2002; 37(2): 89-96 -
ArticleMarch 31, 2003
0
626
90
Detection of Residual Leukemia with Reverse Transcription-polymerase Chain Reaction from Patients with AML1/ETO Positive Acute Myeloid Leukemia in Remission
Kyoung Bun Park, Jae Jin Lee, Hwi Joong Yoon, Si Young Kim, Young Il Kim, Kyung Sam Cho
Korean J Hematol 2003; 38(1): 15-23 -
ArticleDecember 31, 2003
0
780
76
Haplotype Mismatch Transplantation using High-dose CD34+ Cells with Stratified New Conditioning Regimens in Patients with Acute Myeloid Leukemia.
Hee Je Kim, Woo Sung Min, Soo Mi Choi, Dong Gun Lee, Yoon Hee Park, Jong Wook Lee, Jong Wong Park, Chun Choo Kim
Korean J Hematol 2003; 38(4): 221-227 -
ArticleMarch 31, 2004
0
941
144
Single Center Experience of Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia
Woo Jin Sung, Joon Ho Moon, Seok Bong Jeon, Dong Hwan Kim, Jong Gwang Kim, Sang Kyun Sohn, Kyu Bo Lee, Jang Soo Suh, Kun Soo Lee
Korean J Hematol 2004; 39(1): 16-22 -
ArticleSeptember 30, 2004
0
1026
145
High-dose Cytarabine, Etoposide and Cisplatin Salvage Chemotherapy for Relapsed Adult Acute Myeloid Leukemia
JongSeok Lee, JongMu Sun, Yongsang Hong, Jihyun Kim, SungSoo Yoon, Seongyang Park, ByoungKook Kim, KyungWon Lee, WonSup Lee, JungHun Kang
Korean J Hematol 2004; 39(3): 134-140 -
Original ArticleSeptember 30, 2007
1
818
96
FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype
Sang Ho Kim, Yeo Kyeoung Kim, Il, Kwon Lee, Deog Yeon Jo, Jong Ho Won, Jae Yong Kwak, Chang Yeol Yim, Moo Rim Park, Deok Hwan Yang, Sang Hee Cho, Je Jung Lee, Ik Joo Chung, Hyeoung Joon Kim
Korean J Hematol 2007; 42(3): 250-257 -
Original ArticleJune 30, 2009
0
880
84
Prognostic Significance of FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype
Ja Young Lee, Young Don Joo, Seung Hwan Oh, Jeong Hwan Shin, Hye Ran Kim, Sang Min Lee, Jeong Nyeo Lee
Korean J Hematol 2009; 44(2): 74-81 -
Case ReportSeptember 30, 2009
0
1324
111
A Case of Acute Myeloid Leukemia with Mediastinal Sarcoma
Young Hee Nam, Ji Hyun Lee, Kyung A Kwon, Suee Lee, Sung Yong Oh, Sung Hyun Kim, Hyuk Chan Kwon, Jin Yeong Han, Sook Hee Hong, Hyo Jin Kim
Korean J Hematol 2009; 44(3): 148-152 -
Case ReportDecember 30, 2009
0
1412
58
Long-term Complete Remission in a 71-year-old Patient with AML-M7 after Low-dose Cytarabine Induction and Intermediate-dose Cytarabine Consolidation Treatment
Ji Hyun Kwon, Ji Won Kim, Jin Hyun Park, Young il Koh, Jee Hyun Kim, Su Mi Bang, Jung han Song, Jong Seok Lee
Korean J Hematol 2009; 44(4): 244-248 -
Original ArticleSeptember 30, 2010
13
1111
142
Clinical utility of FISH analysis in addition to G-banded karyotype in hematologic malignancies and proposal of a practical approach
Won Kyung Kwon, Jin Young Lee, Yeung Chul Mun, Chu Myong Seong, Wha Soon Chung, and Jungwon Huh
Korean J Hematol 2010; 45(3): 171-176 -
Original ArticleMarch 31, 2010
18
1006
239
Prognostic significance of nucleophosmin mutations and
FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemiaYeo-Kyeoung Kim, Hee-Nam Kim, Se Ryeon Lee, Jae-Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Il-Kwon Lee, Myung-Geun Shin, and Hyeoung-Joon Kim
Korean J Hematol 2010; 45(1): 36-45 -
Case ReportJune 26, 2012
7
766
94
Chronic graft versus host disease with small bowel obstruction after unrelated hematopoietic stem cell transplantation in a patient with acute myeloid leukemia
Ju Young Yoon, Hyery Kim, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, and Hyo Seop Ahn
Korean J Hematol 2012; 47(2): 142-145 -
Original ArticleDecember 31, 2013
23
2758
529
Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation
Hee-Jeong Lee, Hyung-Jin Park, Hyun-Wook Kim, and Sang-Gon Park
Blood Res 2013; 48(4): 250-253 -
Original ArticleMarch 31, 2014
12
2208
553
Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
Eunhee Han, Hyeyoung Lee, Myungshin Kim, Yonggoo Kim, Kyungja Han, Sung-Eun Lee, Hee-Je Kim, and Dong-Wook Kim
Blood Res 2014; 49(1): 22-28 -
Case ReportMarch 31, 2010
6
560
62
Synchronous development of KIT positive acute myeloid leukemia in a patient with gastrointestinal stromal tumor
Young-Bin Joo, Seung Hwa Choi, Seung Kyoung Kim, Byungyong Shim, Myung-Shin Kim, and Yoo-Jin Kim
Korean J Hematol 2010; 45(1): 66-69 -
Original ArticleJune 25, 2014
9
1977
729
Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis
Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim, Junsik Hong, Jinny Park, Jae Hoon Lee, Bo Ram Han, Ho Young Kim, Dae Young Zang, Se Hyung Kim, Seong Kyu Park, Dae Sik Hong, Guk Jin Lee, Jong-Youl Jin, and Gyeonggi/Incheon Branch, The Korean Society of Hematology
Blood Res 2014; 49(2): 95-99 -
Review ArticleDecember 31, 2012
17
1218
239
Measurements of treatment response in childhood acute leukemia
Dario Campana, and Elaine Coustan-Smith
Korean J Hematol 2012; 47(4): 245-254 -
Original ArticleSeptember 25, 2012
12
1007
100
Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells
Soo-Jeong Kim, Ji Eun Jang, June-Won Cheong, Ju-In Eom, Hoi-Kyung Jeung, Yundeok Kim, Doh Yu Hwang, and Yoo Hong Min
Korean J Hematol 2012; 47(3): 178-185 -
Case ReportSeptember 25, 2012
8
1105
121
A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Ji Hun Jeong, Jeong Yeal Ahn, Soon Ho Park, Mi Jung Park, Kyung Hee Kim, and Jun Shik Hong
Korean J Hematol 2012; 47(3): 225-228 -
Original ArticleMarch 31, 2013
10
1951
529
Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients
Yundeok Kim, Jieun Jang, Shin Yong Hyun, Dohyu Hwang, Soo Jeong Kim, Jin Seok Kim, Jun-Won Cheong, and Yoo Hong Min
Blood Res 2013; 48(1): 24-30 -
Original ArticleDecember 31, 2015
19
1987
515
Expression and functional roles of the chemokine receptor CXCR7 in acute myeloid leukemia cells
Ha-Yon Kim, So-Yeon Lee, Deog-Young Kim, Ji-Young Moon, Yoon-Seok Choi, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, and Deog-Yeon Jo
Blood Res 2015; 50(4): 218-226 -
Review ArticleDecember 23, 2016
20
3512
1410
Mesenchymal stromal cells in myeloid malignancies
Thomas Schroeder, Stefanie Geyh, Ulrich Germing, and Rainer Haas
Blood Res 2016; 51(4): 225-232 -
Original ArticleSeptember 25, 2017
8
3405
1277
Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia
Jae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, Gi June Min, Sung-Soo Park, Young-Woo Jeon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, and Woo-Sung Min
Blood Res 2017; 52(3): 174-183 -
Original ArticleSeptember 25, 2017
20
3778
1035
Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
Jung Yeon Lee, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, Yundeok Kim, Soo-Jeong Kim, Jin Seok Kim, Shin Young Hyun, Yoo Hong Min, and June-Won Cheong
Blood Res 2017; 52(3): 184-192 -
Original ArticleMarch 31, 2018
10
2746
1122
Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia
Tae Yang Song, Sang Hoon Lee, Gun Kim, Hee Jo Baek, Tai Ju Hwang, and Hoon Kook
Blood Res 2018; 53(1): 25-34 -
Original ArticleSeptember 28, 2018
6
2242
432
The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
Yumi Park, Jinsook Lim, Seonyoung Kim, Ikchan Song, Kyechul Kwon, Sunhoe Koo, and Jimyung Kim
Blood Res 2018; 53(3): 198-204 -
Original ArticleDecember 31, 2018
22
2044
459
Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype
Nargess Arandi, Mani Ramzi, Fatemeh Safaei, and Ahmad Monabati
Blood Res 2018; 53(4): 294-298 -
Review ArticleSeptember 30, 2019
40
4860
1628
Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts
Ezzatollah Fathi, Zohreh Sanaat, Raheleh Farahzadi
Blood Res 2019; 54(3): 165-174 -
Original ArticleSeptember 30, 2019
0
3062
1122
Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD
Dong Won Baek, Jung Min Lee, Ju-Hyung Kim, Hee Jeong Cho, Ji-Yeon Ham, Jang-Soo Suh, Sang-Kyun Sohn, Joon Ho Moon
Blood Res 2019; 54(3): 189-197 -
Review ArticleMarch 31, 2020
8
3160
979
Bibliometric analysis of studies about acute myeloid leukemia conducted globally from 1999 to 2018
Beomjun Seo, Jeeyoon Kim, Seungwook Kim, Eunil Lee
Blood Res 2020; 55(1): 1-9 -
Review ArticleJuly 31, 2020
38
15021
3791
-
Review ArticleJuly 31, 2020
12
6943
1635
-
Review ArticleJuly 31, 2020
16
4077
1339
New agents in acute myeloid leukemia (AML)
Silvia Park, Byung Sik Cho, Hee-Je Kim
Blood Res 2020; 55(S1): S14-S18 -
Original ArticleDecember 31, 2020
3
3455
806
Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
Sujin Choi, Bo Kyung Kim, Hong Yul Ahn, Kyung Taek Hong, Jung Yoon Choi, Hee Young Shin, Hyoung Jin Kang
Blood Res 2020; 55(4): 217-224 -
Review ArticleMarch 31, 2022
7
3512
756
IDH1/2 mutations in acute myeloid leukemia
Ja Min Byun, Seung-Joo Yoo, Hyeong-Joon Kim, Jae-Sook Ahn, Youngil Koh, Jun Ho Jang, Sung-Soo Yoon
Blood Res 2022; 57(1): 13-19 -
Review ArticleApril 30, 2022
24
6261
1262
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res 2022; 57(S1): S32-S36 -
Review ArticleApril 30, 2022
10
3155
931
Human acute myeloid leukemia stem cells: evolution of concept
Dong-Yeop Shin
Blood Res 2022; 57(S1): S67-S74 -
Review ArticleMarch 31, 2023
2
1919
230
The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
Reham Osama Mansour, Shaimaa El-Ashwah, May Denewer
Blood Res 2023; 58(1): 13-19 -
Original ArticleDecember 31, 2023
0
2004
402
Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia
Jung Hwan Lee, Hee Young Ju, Ju Kyung Hyun, So Jin Kim, Hee Won Cho, Jae Kyung Lee, Ji Won Lee, Ki Woong Sung, Keon Hee Yoo
Blood Res 2023; 58(4): 181-186 -
RESEARCHFebruary 19, 2024
0
659
130
Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis
Saba Manoochehrabadi, Morteza Talebi, Hossein Pashaiefar, Soudeh Ghafouri‑Fard, Mohammad Vaezi, Mir Davood Omrani and Mohammad Ahmadvand
Blood Res (2024) 59:4 -
REVIEWApril 15, 2024
0
671
182
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
Young Hoon Park, Dae-Young Kim, Seongkoo Kim, Young Bae Choi, Dong-Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung-Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook, on behalf of Korean Aplastic Anemia Working Party
Blood Res 2022;57: 20-28 -
Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
Blood Res 2022;57: S79-S85
Most Cited
-
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res 2022;57: S32-S36 -
Overview of inherited bone marrow failure syndromes
Meerim Park
Blood Res 2022;57: S49-S54
Editorial Office
+82-2-516-6582
